THOMPSON DAVIS & CO., INC. - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 50 filers reported holding INTERSECT ENT INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2016$5,000
-28.6%
3740.0%0.01%
-20.0%
Q1 2016$7,000
-12.5%
3740.0%0.01%
-9.1%
Q4 2015$8,000
-33.3%
374
-25.1%
0.01%
-35.3%
Q3 2015$12,000
+71.4%
499
+99.6%
0.02%
+112.5%
Q2 2015$7,000
+16.7%
2500.0%0.01%
+14.3%
Q1 2015$6,000
+20.0%
2500.0%0.01%
+16.7%
Q4 2014$5,000
+150.0%
250
+100.0%
0.01%
+100.0%
Q3 2014$2,0001250.00%
Other shareholders
INTERSECT ENT INC shareholders Q3 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,332,773$27,828,0005.75%
First Light Asset Management, LLC 2,036,645$42,525,0002.82%
Altium Capital Management LP 141,856$2,962,0000.82%
PURA VIDA INVESTMENTS, LLC 909,660$18,994,0000.54%
Rock Springs Capital Management LP 1,080,200$22,555,0000.49%
Novo Holdings A/S 508,922$10,626,0000.44%
Davide Leone & Partners Investment Co Ltd. 109,240$2,281,0000.28%
PURA VIDA INVESTMENTS, LLC 256,800$5,362,0000.15%
Bellevue Group AG 617,968$12,903,0000.14%
Gyon Technologies Capital Management, LP 13,318$278,0000.12%
View complete list of INTERSECT ENT INC shareholders